Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed), a US federal funding opportunity from National Institutes of Health (opportunity number PAR-25-247). See the official Grants.gov listing for eligibility, award amounts, and application instructions.